Evidence map›Paper›PMID 38862827›Full record

ArticleCommunications biology2024

Telomeric RNA (TERRA) increases in response to spaceflight and high-altitude climbing.

Taghreed M Al-Turki, David G Maranon, Christopher B Nelson, Aidan M Lewis, Jared J Luxton, Lynn E Taylor, Noelia Altina, Fei Wu, Huixun Du, JangKeun Kim and 8 more

Abstract read
In one paragraph

Article in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Taghreed M Al-Turki *Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, CO, USA.
David G Maranon *Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, CO, USA.
Christopher B NelsonDepartment of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, CO, USA.
Aidan M LewisDepartment of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, CO, USA.
Jared J LuxtonDepartment of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, CO, USA.
Lynn E TaylorDepartment of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, CO, USA.
Noelia AltinaCell and Molecular Biology Program, Colorado State University, Fort Collins, CO, USA.
Fei WuBuck AI Platform, Buck Institute for Research on Aging, Novato, CA, USA.ORCID 0000-0002-8353-7676
Huixun DuBuck AI Platform, Buck Institute for Research on Aging, Novato, CA, USA.
JangKeun KimDepartment of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.ORCID 0000-0002-8733-9925
Namita DamleDepartment of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.
Eliah OverbeyDepartment of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.ORCID 0000-0002-2866-8294
Cem MeydanDepartment of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.ORCID 0000-0002-0663-6216
Kirill GrigorevDepartment of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.
Daniel A WinerBuck AI Platform, Buck Institute for Research on Aging, Novato, CA, USA.
David FurmanBuck AI Platform, Buck Institute for Research on Aging, Novato, CA, USA.
Christopher E MasonDepartment of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA. chm2042@med.cornell.edu.ORCID 0000-0002-1850-1642
Susan M BaileyDepartment of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, CO, USA. Susan.Bailey@colostate.edu.ORCID 0000-0001-5595-9364

Funding

Clinical and Molecular Heterogeneity in the Myelodysplastic SyndromesR01CA249054 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MASON, CHRISTOPHER EDWARD, PARK, CHRISTOPHER Y · 2020 to 2024
$3.5M
The Spatiotemporal Landscape of the Human Brain EpitranscriptomeR01MH117406 · NIMH · WEILL MEDICAL COLL OF CORNELL UNIV · PI MASON, CHRISTOPHER EDWARD · 2018 to 2022
$3.3M
National Aeronautics and Space Administration (NASA) 80NSSC19K0434National Aeronautics and Space Administration (NASA) 80NSSC22K0254National Aeronautics and Space Administration (NASA) NNH18ZTT001N-FG2National Aeronautics and Space Administration (NASA) NNX14AB02GNational Aeronautics and Space Administration (NASA) NNX14AH50GNational Aeronautics and Space Administration (NASA) NNX16AO69ANational Aeronautics and Space Administration (NASA) NNX17AB26GNCI NIH HHS R01 CA249054NIMH NIH HHS R01 MH117406
6 · The paper itself

Abstract

Telomeres are repetitive nucleoprotein complexes at chromosomal termini essential for maintaining genome stability. Telomeric RNA, or TERRA, is a previously presumed long noncoding RNA of heterogeneous lengths that contributes to end-capping structure and function, and facilitates telomeric recombination in tumors that maintain telomere length via the telomerase-independent Alternative Lengthening of Telomeres (ALT) pathway. Here, we investigated TERRA in the radiation-induced DNA damage response (DDR) across astronauts, high-altitude climbers, healthy donors, and cellular models. Similar to astronauts in the space radiation environment and climbers of Mt. Everest, in vitro radiation exposure prompted increased transcription of TERRA, while simulated microgravity did not. Data suggest a specific TERRA DDR to telomeric double-strand breaks (DSBs), and provide direct demonstration of hybridized TERRA at telomere-specific DSB sites, indicative of protective TERRA:telomeric DNA hybrid formation. Targeted telomeric DSBs also resulted in accumulation of TERRA foci in G2-phase, supportive of TERRA's role in facilitating recombination-mediated telomere elongation. Results have important implications for scenarios involving persistent telomeric DNA damage, such as those associated with chronic oxidative stress (e.g., aging, systemic inflammation, environmental and occupational radiation exposures), which can trigger transient ALT in normal human cells, as well as for targeting TERRA as a therapeutic strategy against ALT-positive tumors.

Indexed as

AltitudeSpace FlightTelomereAdultDNA Breaks, Double-StrandedDNA DamageFemaleHumansMaleMiddle AgedMountaineeringRNA, Long NoncodingTelomere HomeostasisRNA, Long Noncoding

Identifiers

PMID38862827
PMCPMC11167063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.